Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung Cancer is a research paper published in International Journal of Molecular Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health (NIH) Director’s Pioneer Award
Grant: DP1OD006779
National Institutes of Health (NIH) Director’s Pioneer Award
Grant: UL1TR001412
National Institutes of Health (NIH) Director’s Pioneer Award
Grant: T15LM012495
National Institutes of Health (NIH) Director’s Pioneer Award
Grant: R25LM014213
National Institutes of Health (NIH) Director’s Pioneer Award
Grant: 60NANB22D168
National Institutes of Health (NIH) Director’s Pioneer Award
Grant: K01DA056690
NLM NIH HHS
Grant: DP1 LM011509
National Institutes of Health
Grant: 5R25LM014213-02
Buffalo Research Innovation in Genomic and Healthcare Technology (BRIGHT) Short-Term Training and Education
National Institutes of Health
Grant: 3T15LM012495-05S1
National Library of Medicine Conference 2022
National Institutes of Health
Grant: 1K01DA056690-01
A translational bioinformatics approach to elucidate and mitigate polypharmacy induced adverse drug reactions
National Institutes of Health
Grant: 5DP1OD006779-02
NOVEL PARADIGMS FOR DRUG DISCOVERY: COMPUTATIONAL MULTITARGET SCREENING
National Institutes of Health
Grant: 3UL1TR001412-08S3
Buffalo Clinical and Translational Research Center
FWCI
1.89
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals